CABA

Cabaletta Bio (CABA)

Cabaletta Bio Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:CABA

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2025/01/13	22:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CABA	Cabaletta Bio Inc
2025/01/13	22:00	GlobeNewswire Inc.	Cabaletta Bio Outlines Strategic Priorities and Anticipated Key Milestones for 2025	NASDAQ:CABA	Cabaletta Bio Inc
2024/11/26	22:00	GlobeNewswire Inc.	Cabaletta Bio to Participate in Upcoming Investor Conferences in December	NASDAQ:CABA	Cabaletta Bio Inc
2024/11/18	21:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CABA	Cabaletta Bio Inc
2024/11/18	21:00	GlobeNewswire Inc.	Cabaletta Bio Presents Positive Clinical Safety and Efficacy Data on CABA-201 at ACR Convergence 2024	NASDAQ:CABA	Cabaletta Bio Inc
2024/11/15	03:28	Edgar (US Regulatory)	Form SC 13G - Statement of Beneficial Ownership by Certain Investors	NASDAQ:CABA	Cabaletta Bio Inc
2024/11/14	21:14	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CABA	Cabaletta Bio Inc
2024/11/14	21:07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CABA	Cabaletta Bio Inc
2024/11/14	21:00	GlobeNewswire Inc.	Cabaletta Bio Reports Third Quarter 2024 Financial Results and Provides Business Update	NASDAQ:CABA	Cabaletta Bio Inc
2024/11/06	22:00	GlobeNewswire Inc.	Cabaletta Bio to Participate in Guggenheim’s Inaugural Healthcare Innovation Conference	NASDAQ:CABA	Cabaletta Bio Inc
2024/10/07	19:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CABA	Cabaletta Bio Inc
2024/10/01	05:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CABA	Cabaletta Bio Inc
2024/09/26	05:30	GlobeNewswire Inc.	Cabaletta Bio to Present New and Updated Clinical Data on CABA-201 in Oral and Poster Presentations at ACR Convergence 2024	NASDAQ:CABA	Cabaletta Bio Inc
2024/08/28	21:00	GlobeNewswire Inc.	Cabaletta Bio to Participate in Upcoming Investor Conferences in September	NASDAQ:CABA	Cabaletta Bio Inc
2024/08/23	07:10	Edgar (US Regulatory)	Form SC 13G - Statement of Beneficial Ownership by Certain Investors	NASDAQ:CABA	Cabaletta Bio Inc
2024/08/08	20:25	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CABA	Cabaletta Bio Inc
2024/08/08	20:07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CABA	Cabaletta Bio Inc
2024/08/08	20:00	GlobeNewswire Inc.	Cabaletta Bio Reports Second Quarter 2024 Financial Results and Provides Business Update	NASDAQ:CABA	Cabaletta Bio Inc
2024/07/02	21:00	GlobeNewswire Inc.	Cabaletta Bio to Participate in the Stifel 2024 Virtual Cell Therapy Forum	NASDAQ:CABA	Cabaletta Bio Inc
2024/06/14	19:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CABA	Cabaletta Bio Inc
2024/06/14	15:00	GlobeNewswire Inc.	Cabaletta Bio Reports Positive Initial Clinical Data from Phase 1/2 RESET-Myositis™ and RESET-SLE™ Trials of CABA-201	NASDAQ:CABA	Cabaletta Bio Inc
2024/06/05	08:27	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CABA	Cabaletta Bio Inc
2024/06/05	08:17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CABA	Cabaletta Bio Inc
2024/06/05	05:32	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CABA	Cabaletta Bio Inc
2024/05/29	21:00	GlobeNewswire Inc.	Cabaletta Bio to Participate in the Jefferies Global Healthcare Conference	NASDAQ:CABA	Cabaletta Bio Inc
2024/05/15	20:53	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CABA	Cabaletta Bio Inc
2024/05/15	20:04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CABA	Cabaletta Bio Inc
2024/05/15	20:00	GlobeNewswire Inc.	Cabaletta Bio Reports First Quarter 2024 Financial Results and Provides Business Update	NASDAQ:CABA	Cabaletta Bio Inc
2024/05/13	21:00	GlobeNewswire Inc.	Cabaletta Bio to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ	NASDAQ:CABA	Cabaletta Bio Inc
2024/03/21	20:00	GlobeNewswire Inc.	Cabaletta Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	NASDAQ:CABA	Cabaletta Bio Inc